SLN
Silence Therapeutics
SLN
SLN
26 hedge funds and large institutions have $218M invested in Silence Therapeutics in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
12% less capital invested
Capital invested by funds: $247M → $218M (-$28.4M)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Holders
26
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$29.7M | |
| 2 | +$3.91M | |
| 3 | +$2.45M | |
| 4 |
ACM
Altium Capital Management
New York
|
+$2.07M |
| 5 |
Legal & General Group
London,
United Kingdom
|
+$288K |
Top Sellers
| 1 | -$21.2M | |
| 2 | -$1.98M | |
| 3 | -$1.54M | |
| 4 |
Morgan Stanley
New York
|
-$289K |
| 5 |
JPMorgan Chase & Co
New York
|
-$157K |